WEEKLY e-ALERT  [ BASIC EDITION ]
Pharma China (www.pharmachinaonline.com) is the most influential English media and source of business intelligence covering the Chinese pharmaceutical sector. Pharma China caters for the growing needs of the international pharmaceutical industry for up-to-date and insightful information and intelligence on China’s burgeoning but increasingly complex healthcare marketplace, and is subscribed by most MNC pharma companies, leading CROs, investment banks, consulting firms active in China as well as relevant industry associations and government agencies.

Note: To view full text of free articles, you need to register as a basic member first and then log in. To view premium articles, you need to subscribe to Pharma China as a premium member. For more information or subscription, please contact info@pharmachinaonline.com. If you wish to unsubscribe from this e-Alert, please reply this e-mail with "Remove" in the subject line.
Case Studies
AstraZeneca Plots China Robot Offensive to Counter Price Cuts(9/19/2018 )  (Premium)
Fosun Pharma Sees 'Huge' Opportunities in India, Southeast Asia, Africa(9/18/2018 )  (Premium)
Editor´s Picks
Impending Tariffs on China to Impact Manufacturers of Dietary Supplements, OTC Drugs and Cosmetics(9/21/2018 )  (Premium)
Should You Look At China For Your Next Clinical Trial?(9/20/2018 )  (Premium)
R&D Cooperation Between China and Western Pharma Companies Up 70%(9/18/2018 )  (Premium)
The Market
Nicholas Hall Reports Growth of Chinese OTC Dermatologicals Market in MAT 06/2018(9/20/2018 )  (Premium)
Industry News
China Medical System Signs License and Partnership Deal with VAXIMM AG(9/20/2018 )  (Premium)
Allergan to Build First Medical Aesthetics Innovation Center in China(9/20/2018 )  (Premium)
BeiGene Selects GE's KUBio for Its mAb Facility in Guangzhou(9/20/2018 )  (free)
Wuxi AppTech Submitted $1B+ IPO Application in Hong Kong(9/20/2018 )  (Premium)
Roche Announces Plan to Build An Innovation Center in Shanghai(9/20/2018 )  (Premium)
Merck Slashes Price of Anticancer Keytruda for China Launch(9/19/2018 )  (Premium)
Lilly China and Microsoft Enter Digital Health Partnership Using AI to Empower Medical Innovation in China(9/19/2018 )  (Premium)
Novartis and Tencent Enters Strategic Partnership for Digital Medicine(9/19/2018 )  (Premium)
Novo Nordisk to Axe 400 Research Staffs in Demark and China As It Refocuses R&D(9/18/2018 )  (Premium)
Congenica Announces Market Access Partnership with Digital China Health(9/18/2018 )  (free)
Regulatory News
CPA Releases Announcement for Excessively-Supplied Drug Products (4th Batch)(9/21/2018 )  (Premium)
CDE Solicits Comments on Core Considerations for Clinical Protocol Design of Adalimumab Biosimilar(9/20/2018 )  (Premium)
CDE Seeks Comments on Draft Chinese Translations of Seven ICH Guidelines(9/20/2018 )  (Premium)
General Health
NHC Issues Numerous Clinical Guidelines(9/21/2018 )  (Premium)
Fitch: Increased Use of Technology Will Improve Healthcare Access in China(9/21/2018 )  (Premium)
State Council Introduces New Policy to Improve the National Essential Drug System(9/19/2018 )  (Premium)
NHC Issues Regulation to Improve Health and Medical Big Data Management(9/18/2018 )  (Premium)
NHC Issues the Provisions for Clinical Application of Medical Technologies(9/17/2018 )  (Premium)
NHC Issues Three New Rules to Guide and Regulate Development of Internet Medicine(9/17/2018 )  (Premium)
Product/R&D News
Innovent Reports Clinical Data of Sintilimab as First-line NSCLC Treatment(9/20/2018 )  (Premium)
CBT Pharma Initiates the APOLLO Oncology Clinical Trials Program(9/18/2018 )  (Premium)
People in the News
Recent Executive Moves(9/21/2018 )  (Premium)
Top News Worldwide
Top 25 Global Pharmaceutical Companies by Market Cap 2018(9/18/2018 )  (Premium)
© Wicon International GroupˇˇSupport by: www.heightow.com Home | Site map | Contact Us | Links